Medicinal plants constitute an important reservoir of plant-derived bioactive compounds with multi‑target pharmacological properties. Astragalus membranaceus, Atractylodes macrocephala, Angelica sinensis, and Saposhnikovia divaricata are representative medicinal‑plant resources with distinct phytochemical fingerprints. This work adopted network pharmacology and molecular docking to characterize plant‑derived bioactive constituents originating from Manzhi Guben Granules (MZGB), and to explore their potential molecular mechanisms using chronic bronchitis (CB) as a disease model. A total of 47 plant‑derived bioactive ingredients were screened from the TCMSP database. By intersecting compound‑targets with CB‑related targets retrieved from GeneCards, OMIM and DrugBank databases, 93 overlapping potential targets were obtained. Ingredient‑target and protein‑protein interaction (PPI) networks were subsequently constructed. GO and KEGG enrichment analyses revealed that these plant‑derived compounds mainly modulate inflammation‑ and apoptosis‑associated signaling cascades including PI3K‑Akt, IL‑17, TNF, and AGE‑RAGE pathways. Molecular docking validated that core plant‑originated compounds such as quercetin and formononetin exhibited stable binding to hub proteins JUN, TP53, MAPK1, AKT1 and ESR1 (binding energy ≤ −5.7 kcal/mol), among which quercetin displayed superior affinity toward MAPK1 and AKT1. This study demonstrates that diverse plant‑derived bioactive metabolites from four medicinal herbs exert synergistic effects of anti‑inflammation, anti-oxidative stress, and suppression of airway remodeling, providing phytochemical-oriented theoretical evidence for understanding MZGB and further exploitation of these medicinal‑plant resources against chronic bronchitis.
Keywords: Manzhi Guben Granules; Plant‑Derived Bioactive Compounds; Network Pharmacology; Molecular Docking; Chronic Bronchitis